SPRAVATO® (esketamine) is the first FDA-approved nasal spray for adults with treatment-resistant depression. Used in combination with an oral antidepressant, Spravato has been shown to quickly and effectively treat depression. FDA-approved in 2019, Spravato is covered by many insurance companies and administered right in our office. Spravato a self-administered nasal spray that is handed to you to administer. You then relax in our office while we supervise your treatment. Relief is often immediate.
There is hope…
and we’re here to help.